Abbott Laboratories' HeartMate 3 heart pump for advanced heart failure kept more patients alive for two years with fewer incidents of stroke than the company's prior left ventricular assist device ...

The US Food and Drug Administration has approved the HeartMate 3 left ventricular assist system (Abbott) as a long-term destination therapy for patients with advanced heart failure who are ineligible ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

A six-month analysis of the pivotal MOMENTUM 3 trial found that patients implanted with the new HeartMate 3 left ventricular assist system (LVAS) had fewer adverse clotting and bleeding events than ...

MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...

There are more people in need of new hearts than there are hearts available — that's a big reason companies like Abbott Laboratories and Medtronic sell advanced implantable pumps called ...

PLEASANTON, Calif., Thoratec Corporation, a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced the first ever HeartMate 3™ implant ...

Abbott Laboratories, Inc. ABT recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump). The development, meant exclusively ...

Thousands of patients experiencing heart failure may have increased life expectancy when using Abbott Medical Devices HeartMate 3 heart pump, according to recently released data from the company’s ...

Shares of St. Jude Medical Inc.STJ rose nearly 2.2% yesterday, following the CE Mark approval for HeartMate 3 Left Ventricular Assist System (LVAS) in Europe. The company will start to commercialize ...

An Abbott recall concerns more than 1,500 of the tablet apps used to communicate with and control its implanted long-term heart pumps, after reports that software issues could cause the pumps to stop ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.